The life-saving secrets in your baby's DNA | Robert C. Green

Summary

---

TED Talks Daily – Episode Summary

Title: The life-saving secrets in your baby's DNA
Speaker: Dr. Robert C. Green
Date: September 12, 2025
Host: Elise Hu

---

Episode Overview

In this thought-provoking TED Talk, Dr. Robert C. Green, professor of medicine at Harvard Medical School, explores a transformative vision for medical care: sequencing every newborn’s DNA at birth. Green outlines the remarkable power of preventive genomics, shares the story and insights from the pioneering BabySeq project, and paints a compelling future where genome-informed medicine proactively protects health before illness can take root.

---

Key Discussion Points and Insights

The Problem: Diagnostic Odyssey in Pediatric Illness (03:21)

• Dr. Green describes the agony parents experience when a child is sick and doctors struggle to diagnose the cause.
• Traditional genetic testing often happens too late, after irreversible damage has occurred.
• Many genetic conditions are already treatable, and this number is growing with new therapies.

The Breakthrough: The BabySeq Project (04:30)

• In 2015, BabySeq became the first controlled trial to comprehensively sequence healthy newborns’ genomes.
• Initial reactions from the medical community were skeptical and concerned; fears included psychological harm, unnecessary medical interventions, and high costs.
• Over a decade, the team has extensively studied the medical, economic, and emotional impacts of newborn sequencing—findings so far are “pretty reassuring.”

Surprising Findings from Sequencing Healthy Babies (05:45)

• Among ~1,000 families, sequencing just 400 treatable-condition genes revealed that 4% of babies carry mutations.
• Expanding the analysis to 5,000 genes (including conditions emerging in adulthood) showed 12% of babies with mutations.
  • "If this holds, that means in the United States, there's over 400,000 babies a year that will carry these risk mutations. And worldwide, that's over 15 million babies a year..." (06:54)
• Individually rare diseases, collectively, represent a massive medical challenge.

Real Stories: Genomics in Action

Testimonies from parents in the study—powerful and memorable:

• Baby Adam: Detected with a gene linked to narrowed aorta; clinicians could monitor and treat promptly.
  • "Finding out that your newborn has a heart problem, of all things, is absolutely terrifying. But knowing that we could be proactive gave us some peace of mind...” (08:00)
• Baby Cora: Found with mutations causing biotinidase deficiency; daily vitamins are keeping her healthy.
  • "We give her a daily vitamin to treat her enzyme deficiency. ... I'm just glad we discovered the conditions before there were any symptoms." (08:42)
• Baby Jacob: Had a BRCA2 mutation, indicating cancer risk—unknown to the family until sequencing. The mother also carried the mutation and chose preventative, life-saving surgery.
  • "It turns out that I ultimately was carrying a mutation. I had risk reducing and ultimately life saving surgery. And I believe it was the right decision so I could be present for my son." (09:19)

Systemic Barriers to Adoption (09:32)

• Current newborn screening programs test for only about 75 treatable conditions but haven’t kept pace with advances—adding just 9 new ones since 2008.
• Psychological barriers: Parents' reluctance to “look for something wrong” in their healthy babies.
• Privacy concerns frequently cited, but Dr. Green notes medical DNA data has protections—sometimes more robust than those for other personal data.
• Direct-to-consumer genetic companies don’t offer clinically rigorous sequencing and aren’t held to the same standards as medical providers.

The Bigger Vision: Preventive, Genome-Informed Medicine (11:10)

• Genomics is just one part of a coming revolution including multiomics, proteomics, and wearable tech—tools to keep us healthy rather than merely treating illness.
• Dr. Green co-founded an international consortium with 27 groups studying newborn sequencing, sharing data across nations.
• "We feel like we're inventing an entirely new field of medicine." (11:58)

Future Directions: AI and Continuous Genome Analysis (12:16)

• The science and its interpretations are constantly evolving, but your child's DNA doesn’t change.
• The vision: Sequence once, then reanalyze as new medical knowledge and treatments emerge—using AI-enhanced digital health platforms for scalable, repeated genome interpretation.
• This will require courage and a shift in mindset toward embracing knowledge of risk—“to preserve our health rather than waiting... to get sick and treating them there.” (13:31)

---

Notable Quotes & Memorable Moments

• On collective impact:
  "These are individually rare diseases... but together, they are a massive medical problem." (07:17)
• On parental experience:
  "Knowing that we could be proactive gave us some peace of mind that we were doing everything we could do instead of being surprised down the road." (08:08, Baby Adam’s parent)
• On the paradox of privacy:
  "If somebody steals my genome, they really can't make much of it. Whereas if they steal my electronic footprint... there's a lot more harm that can be done." (10:15)
• On vision for the future:
  "We should sequence your child's DNA and we should revisit and reanalyze that DNA over and over again to truly create the dream of genome informed medicine." (12:44)
• Call to action:
  "...if we can embrace this, we can save millions of lives and usher in an entirely new era of genome inspired medicine." (13:52)

---

Timestamps of Key Segments

• 03:21 – Introduction to the diagnostic challenges in pediatric care and the origins of the BabySeq project.
• 05:45 – Results of sequencing healthy infants; prevalence of risk mutations.
• 08:00 – 09:19 – Personal stories of families benefiting from newborn sequencing.
• 09:32 – 11:10 – Barriers: psychological, privacy, and systemic inertia.
• 11:10 – 12:16 – Global consortium, future fields in preventive health.
• 12:16 – 13:52 – The vision for lifelong, AI-assisted genomic monitoring.
• 13:52 – End – Final call to action and conclusion.

---

Tone and Language Notes

Dr. Green’s tone is both authoritative and empathetic, blending statistical insight with moving real-world anecdotes. He emphasizes hope, prevention, and the importance of embracing change in medicine—urging listeners to be courageous in reimagining pediatric health care.

---

For Listeners Who Haven’t Heard the Episode

This summary conveys Dr. Robert C. Green's pioneering vision for using genomic sequencing at birth as the foundation of a new, proactive kind of medicine. By sharing compelling statistics, honest reflections on risks and public hesitancy, and emotional parent experiences, the episode highlights just how close we are to redefining what it means to keep children healthy—or to prevent disease before it ever strikes.

Transcript

[Capital One Advertiser]

If you love to travel, Capital One has a rewards credit card that's perfect for you. With the Capital One Venture X card, you earn unlimited double miles on everything you buy. Plus, you get premium benefits at a collection of luxury hotels when you book on Capital One Travel. And with Venture X, you get access to over 1,000 airport lounges worldwide. Open up a world of travel possibilities with a Capital One Venture X card. What's in your wallet?

[Dr. Robert C. Green]

20 terms apply Lounge access is subject to change. See capitalone.com for details.

[WISE Advertiser]

This podcast is brought to you by WISE, the app for international people using money around the globe. With Wise, you can send, spend and receive up to 40 currencies with only a few simple taps and save up to 55% compared to major banks. Plus, wise won't add hidden fees to your transfer. Whether you're buying souvenirs with pesos in Puerto Vallarta or sending Euros to a loved one in Paris, you know you're getting a fair exchange rate with no extra markups. Be Smart Join the 15 million customers who choose WISE. Download the WISE app today or visit WISE.com Learn more by visiting WISE.com US Compare T's and C's Apply.

[Elise Hu]

This episode is sponsored by Grow Therapy when life feels overwhelming, talking to the right person can create profound shifts in how we navigate challenges. Therapy isn't just about crisis management. It's about building emotional intelligence and resilience. But finding a therapist shouldn't add to your stress. GrowTherapy makes this process actually manageable. They connect you with thousands of licensed therapists across the US Offering both virtual and in person sessions. You can search by insurance, specialty and treatment approach to find someone who genuinely fits your needs. If it's not the right match, switching is straightforward. No subscriptions or long term commitments. Whether you're dealing with work anxiety, relationship dynamics or life transitions, quality mental health care should be accessible on your schedule. Evenings, weekends, whatever works for you, whatever challenges you're facing, GrowTherapy is here to help. Sessions average about $21 with insurance, and some pay as little as zero depending on their plan. Visit growththerapy.comted today to get started. That's growtherapy.comted growthherapy.ted availability and coverage vary by state and insurance plan. You're listening to TED Talks daily, where we bring you new ideas to spark your curiosity every day. I'm your host, Elise Hu. Genome Informed Medical care is becoming better known, especially in cancer care. But what if we could take individualized medicine? A huge step forward? In his talk, Dr. Robert C. Green, professor of medicine at Harvard Medical School, shares a big idea. Imagine a world where we're able to treat people before they ever get sick. For Robert, that means sequencing a person's entire DNA when they're born so that as that child grows and science progresses, scientists and doctors are able to revisit and reanalyze that DNA over and over again to identify genetic conditions before they strike. He lays out this work, how AI is involved, and more coming up.

[Dr. Robert C. Green]

So on April 22, 2015, a four day old baby girl in Boston, let's call her baby Maria, became the first healthy infant in human history to have her genome comprehensively sequenced, comprehensively analyzed as part of a clinical controlled trial in preventive genomics. Now why is this important? It's great to be first, but it's important because when children are ill, everybody's upset. But when children remain ill and doctors can't figure out what's going on, well, that casts their parents into a diagnostic odyssey that can take years and be incredibly agonizing. It can create all sorts of misunderstanding, misdiagnosis and mismanagement. Now, sometimes those children will go on to get genetic testing and sometimes they'll find an answer. Sometimes those answers mean that you can treat the child, but by then it can be too late. The damage is permanent. This is particularly tragic because there are so many treatable genetic conditions today and there are going to be even more with gene editing, cell and gene therapies. In fact, it's been suggested that over 90% of genetic conditions will be treatable in the next few years with gene editing. So the key to this is obviously finding these children early, actually analyzing their DNA at or shortly after birth. And so 10 years ago, I pulled together a team at Harvard Medical School, Mass General, Brigham Broad Institute, Ariadne Labs, and got together with a brilliant group of co leaders, Alan Beggs, Amy McGuire, Heidi Rehm and Ingrid Holm. And together we launched the Baby seq, or Baby Sequencing Project, the world's first trial of newborn genomic sequencing. Now, when we presented this information at medical meetings, we didn't quite get the reaction we were hoping for. People were aghast. They thought we were going to do terrible medical things to these children. They thought there was going to be catastrophic psychological distress and they thought we were going to spend all sorts of money. So we've spent 10 years exquisitely studying the medical, behavioral and economic impact of newborn genetic sequencing. We don't have all the answers yet, but I have to tell you that what we've Discovered so far is pretty reassuring. Now, what was really surprising about this was what we found in these normal babies. If you take, let's say, 400 genes, which represent conditions that are treatable today, absolutely treatable, in about 1,000 families, we found mutations in those genes in about 4% of these babies. 4%. If you expanded that gene list to be, let's say, 5,000 genes long, that includes conditions that aren't treatable yet, conditions that maybe attack you in adulthood. We found an incredible 12% of these babies were carrying such mutations. Now, remember, that doesn't mean that all of these children are going to get the disease, but it does mean that if you know the risk that the children have, then your pediatrician and your family can be on the lookout for vague symptoms that would otherwise be overlooked. This isn't a small problem. If this holds, that means in the United states, there's over 400,000 babies a year that will carry these risk mutations. And worldwide, that's over 15 million babies a year that will carry these risk mutations. It's kind of ironic, isn't it, because these are individually rare diseases, Many of them you won't even have heard of. But together, they are a massive medical problem. Let me let you hear from a couple of the baby Seek mothers who've gone through this and hear what they have to say about the findings in their own children. Now, this was baby Adam, who had an elastin gene mutation, which can be associated with a narrowed aorta.

[Podcast Sponsor Announcer]

Finding out that your newborn has a heart problem, of all things, is absolutely terrifying. But knowing that we could be proactive gave us some peace of mind that we were doing everything we could do instead of being surprised down the road.

[Dr. Robert C. Green]

In fact, after this mutation was found, a scan found that this baby's aorta was already mildly narrowed. It can now be followed and treated if it gets worse. Baby Cora, who's now almost nine years old, was found to have mutations suggestive of biotinidase deficiency, which is absolutely necessary for proper brain development. So she takes a simple dietary supplement every day that's kept her brain safe.

[Podcast Sponsor Announcer]

We give her a daily vitamin to treat her enzyme deficiency. We had to get creative at first, but now it's part of our routine. I'm just glad we discovered the conditions before there were any symptoms.

[Dr. Robert C. Green]

And baby Jacob was one of four children who had mutations that created a predisposition for pediatric or adult onset cancers. Now, in his case, the gene was BRCA2 or BRCA2, and nobody in the family knew that it was present. When we found out, we traced it back to his mother who was surprised, but who could then take action.

[Podcast Sponsor Announcer]

It turns out that I ultimately was carrying a mutation. I had risk reducing and ultimately life saving surgery. And I believe it was the right decision so I could be present for my son.

[Dr. Robert C. Green]

So how can we bring this to every family that wants this insight? Well, there is a newborn screening system around most of the world. It looks for in the United states up to 75 treatable conditions, mostly metabolic conditions. But that system is overburdened under resourced and since 2008 it's only added nine new conditions. And as we've just said, there are several hundred treatable genetic conditions today. But it's going to be very hard for them to keep up. Why are people so resistant? Why aren't we demanding this? Well, part of the reason is human psychology, right? You bring home this perfect little baby and you don't really want to look for something that might be wrong, even if intellectually, you know, it might be treatable. But we've got to get past that. The other reason is privacy concerns, and this is sort of ironic because privacy concerns are real. Your DNA is a biometric, it's kind of like a fingerprint. There's certainly some law enforcement considerations, but if somebody steals my genome, they really can't make much of it. Whereas if they steal my electronic footprint or your electronic footprint, there's a lot more harm that can be done. So I'm not saying we shouldn't be concerned about privacy. In fact, privacy is protected when you look for genomic information in a medical context, just like it's protected for your psychiatric history and your HIV status and so forth. It's also been confusing to have direct to consumer genetic testing. Now these companies for the most part were very honest about what they offered, but they were not protected by these same legal protections as healthcare. And typical direct to consumer companies use a technology called genotyping. So they're looking for various markers in the genome, which is good for ancestry and traits, but not so good for mutations. For that you really need the sequencing every single letter of the DNA and that's 5,000 times more granular. I also think there is a systematic or institutional resistance, right, because genomics is the tip of the spear for preventive care. It's really the first in a series of things that we need to bring in order to preserve our health. Multiomics, proteomics, transcriptomics, wearables, all the exciting things we've heard about that will keep us well instead of simply treating us when we're sick. Now, I'm happy to tell you that I've co founded an international consortium on newborn sequencing. It's grown to 27 groups around the world. They're all doing this in different health care systems. We get together, we compare notes, we share data. It's really exciting. I go to these annual meetings. It's the most exciting meeting I go to every year. We feel like we're inventing an entirely new field of medicine. But if we really want to invent the future, we've got to do something different. If we really want to invent the future, we've got to realize that a child's DNA doesn't change over time, but the science is changing all the time. And so what that means is we should sequence your child's DNA and we should revisit and reanalyze that DNA over and over again to truly create the dream of genome informed medicine. Because each and every year there will be new insights and new treatments available. Well, this isn't offered anywhere in the world, but I'm happy to tell you that we are trying to build this. We are building an AI enhanced digital health platform so that you, your grandchildren, your children, your pediatricians, your healthcare centers, your employers, your nations can do this at scale. It's going to take a certain amount of courage to change the way we think about disease, to embrace the knowledge of risk in order to to preserve our health rather than waiting for us and our children to get sick and treating them there. But if we can do this, if we can embrace this, we can save millions of lives and usher in an entirely new era of genome inspired medicine. Thank you.

[Elise Hu]

That was Robert C. Green speaking at TED 2025. If you're curious about TED's curation, find out [e-mail] curationguidelines and that's it for today. TED Talks Daily is part of the TED Audio Collective. This talk was fact checked by the TED research team and produced and edited by our team, Martha Estefanos, Oliver Friedman, Brian Greene, Lucy Little and Tansika Songmanivong. This episode was mixed by Christopher Faizy Bogan. Additional support from Emma Tobner and Daniela Balarazo. I'm Elise Hu. I'll be back tomorrow with a fresh idea for your feedback. Thanks for listening.

[Podcast Sponsor Announcer]

This episode is brought to you by Capital One. Capital One's tech team isn't just talking about multi agentic AI. They already deployed one. It's called Chat Concierge and it's simplifying car shopping using self reflection and layered reasoning with live API checks. It doesn't just help buyers find a car they love, it helps schedule a test drive, get pre approved for financing and estimate trade in value. Advanced, intuitive and deployed. That's how they stack. That's technology at Capital One. Imagine a world of extraordinary comfort where bowl and branch bedding wraps you in the softest. Embrace the coziest experience made from the world's finest 100% organic cotton, all so you can sleep better. Start building your fall sanctuary with Bolen Branch's iconic Signature sheets made with a buttery, breathable weave that gets softer with every wash. Enjoy 15% off your first set of sheets with free shipping and returns at B O L L& Branch.com with code BUTTERY. See site for details and exclusions.

[WISE Advertiser]

Skincare routines felt overwhelming until I found Penoxyl. With breakout fighting tools like the best selling foaming wash with 10% benzoyl peroxide, pimple patches and Acne fighting body spray, Panoxyl makes a difference I can see and feel. Dermatologists recommended and trusted for over 50 years, it's clear why panoxyl is the acne authority. Find your clear skin [e-mail] or on Amazon.